Solventum
Healthcare conglomerate making wound care, dental products, and hospital coding software.
On the record
Checkpoint: Q2 2026 earnings report showing HIS segment organic growth versus company average
The call
Wound care and dental keep the lights on while AI-native scribes chip away at the software business that was supposed to drive growth.
Solventum makes wound-care products, dental supplies, and health record software for hospitals and doctors. The physical products are hard to replace because hospitals need reliable bandages and dental tools, but the software part is getting attacked by newer AI companies like Abridge and Ambience that write down patient notes automatically, much faster and cheaper than the old way. The big question is whether Solventum's software can keep its customers or if hospitals will switch to these faster AI tools that are already winning most new sales.
Why
01
AI pressure: Abridge, Ambience Healthcare, Microsoft/Nuance DAX. AI-native scribes already grab roughly 70% of new ambient-documentation business, squeezing Solventum's Health Information Systems unit. Could AI do the core job? Only partly.
02
Bigger players: Epic Systems. Epic is building native autonomous coding into its EHR platform, threatening to cut Solventum's software out of the hospital workflow entirely. Could a giant copy it? Probably.
03
What protects it. Wound care and dental products are physical goods AI can't touch, and coding software sits inside 75%+ of US hospitals already.
What would change this call
HIS segment organic growth rate reported at Aug 6, 2026 earnings versus company-wide average. Below-average HIS growth would confirm the software unit is losing share to AI-native rivals.
A named hospital system publicly drops Fluency for Abridge, Ambience, or Nuance DAX. Direct evidence of installed-base defection to AI-native ambient documentation competitors.
Epic announces native autonomous coding shipped at scale to health systems. Would show the dominant EHR incumbent closing the gap Solventum's HIS unit depends on.
A named hospital system publicly drops Fluency for Abridge, Ambience, or Nuance DAX. Direct evidence of installed-base defection to AI-native ambient documentation competitors.
Epic announces native autonomous coding shipped at scale to health systems. Would show the dominant EHR incumbent closing the gap Solventum's HIS unit depends on.
Key numbers
- Market cap $14.1B, stock $79.61 vs $96.05 high
- FY2026 guided organic growth just 2.0-3.0%
- HIS software used in 75%+ of US hospitals
Named risks
- Patient data breach disclosed March 29, 2026 has triggered six class-action lawsuits by June 2026.
- AI-native ambient-scribing startups already hold ~70% of the market Solventum's Fluency products compete in.
- Company still exiting 3M Transition Services Agreements, targeting ~90% by end-2026, an execution risk.
- Active patent infringement litigation over negative-pressure wound therapy technology as of May 2026.
- Headcount declined 6.44% year over year as of December 31, 2025 amid restructuring.
Rivals, as read in July 2026
| Rival | Direction | Evidence |
|---|---|---|
| Abridge / Ambience | losing to | AI-native startups hold ~70% of ambient clinical-scribing market as of mid-2026, per Menlo Ventures |
| Epic | contesting | Epic's native EHR coding capability sits inside Solventum's HIS installed base as a structural threat |
| Microsoft/Nuance | contesting | Nuance DAX competes directly with Solventum's Fluency Align and Fluency Direct dictation tools through 2026 |
| Smith+Nephew, Convatec, Molnlycke | contesting | Compete in advanced wound care, a segment Solventum still holds via MedSurg as of 2026 |
| Dentsply Sirona, Envista, Straumann | contesting | Compete in dental solutions segment against Solventum's Dental division as of 2026 |
Questions people ask
- Is Solventum profitable in 2026?
- Yes. Solventum reported FY2025 net income of $1.556 billion, with Q4 2025 sales of $2.0 billion (+3.5% organic). Q1 FY2026 adjusted EPS came in at $1.48, beating consensus of $1.34, reported May 5, 2026.
- Who owns Solventum after the 3M spinoff?
- Solventum became fully independent on April 1, 2024 when 3M spun off its health care business. 3M initially retained about 19.9% ownership post-spinoff; the company now trades on NYSE as SOLV with a market cap near $14.1 billion as of July 20, 2026.
- Could AI replace Solventum's health information systems business?
- Partially. AI-native startups like Abridge and Ambience already hold roughly 70% of the ambient clinical-scribing market as of mid-2026, pressuring Solventum's Fluency dictation and coding tools, though its coding software still integrates deeply with an estimated 75%+ of US hospitals.
- Is Solventum laying off employees?
- Headcount is shrinking amid restructuring: StockAnalysis.com reported 20,584 employees as of December 31, 2025, down 1,416 (-6.44%) year over year, alongside ongoing 'Transform for the Future' cost-cutting targeting about $500 million in multiyear savings.
- Who is Solventum's biggest competitor?
- It varies by segment: Smith+Nephew and Convatec in wound care, Dentsply Sirona and Envista in dental, and Epic, Microsoft/Nuance, and Oracle/Cerner in health information systems, where AI-native ambient-scribing startups are the newest competitive threat as of 2026.
- What is Solventum's revenue guidance for 2026?
- Solventum guided FY2026 organic sales growth of 2.0-3.0% (3.0-4.0% excluding SKU exits) with adjusted EPS of $6.40-$6.60, issued February 26, 2026 alongside Q4 2025 results showing $2.0 billion in quarterly sales.
Timeline
- 2026-05-05Q1 FY2026 results: $2.0B sales, adjusted EPS $1.48 beats $1.34 consensus
- 2026-04-19Threat actor SeraphimGroup claims responsibility for HIS data breach
- 2026-03-29Data breach disclosed at Solventum Health Information Systems affecting patient PHI
- 2026-02-26Q4 2025 results reported; FY2026 guidance issued (2.0-3.0% organic growth)
- 2025-12-23Completed acquisition of Acera Surgical for $725M upfront plus $125M contingent
- 2025-09-02Completed sale of Purification & Filtration business to Thermo Fisher, ~$3.4B net proceeds
- 2025-02-25Announced sale of Purification & Filtration business to Thermo Fisher for $4.1B
- 2024-04-013M completes spin-off of Solventum as independent public company
- 2023-11-163M reveals 'Solventum' as new name for planned independent health care spinoff
Revision history
20 July 2026
First assessed. Protection under test. The text above is fixed as of this date and is not edited afterwards.
In the same band
Sources
- 3M Completes Spin-off of Solventum (2024-04-01)
- Medical Product Outsourcing (2025-08-07)
- Solventum (Wikiwand)
- gurufocus.com (2026-07-20)
- Solventum Reports Q4 2025 Financial Results (2026-02-26)
- MarketWatch (2026-03-14)
- Investing.com (2026-05-05)
- PRNewswire (2026-02-26)
- MarketBeat (2026-02-28)
- Solventum 2025 Year-End Shareholder Letter (2025-12-16)
- GrowthShareMatrix.com (2026-04-15)
- Solventum Corporate Fact Sheet (2026-01)